We speculated that the cell survival and NF-κB regulator A20, or Tumor Necrosis Factor α inducible protein 3 (TNFAIP3), was one molecular target with a greater role in glioma than currently understood [38],[39]. This evidence concerns the gene TNFAIP3 and central nervous system cancer.